Atopic dermatitis (eczema) trials in Germany

In Germany 32 Also abroad 251

32 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Where
Ahaus, Augsburg, Berlin, Bernau bei Berlin, Bielefeld, Buxtehude, Erlangen, Gladbeck, Großenhain, Haslach im Kinzigtal, Hersbruck, Karlsruhe, Koblenz, Langenau, Lübeck, Mainz, Oberursel, Oranienburg, Pforzheim, Quedlinburg, Regensburg, Remscheid
Age
12 years and over
People
1,000 worldwide
Run by
Galderma R&D
See details and how to joinNCT06988605
Phase 2Taking people
Study to Evaluate Soquelitinib in Participants With Moderate to Severe AD
Where
Augsburg, Berlin, Dresden, Frankfurt Am Main, Luebeck, Muenster
Age
18 years and over
People
200 worldwide
Run by
Corvus Pharmaceuticals, Inc.
See details and how to joinNCT07441395 · EU 2025-524384-20-00
No phaseTaking people
Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital Impact
Where
Augsburg, Lübeck
Age
18 years and over
People
30
Run by
University Hospital Schleswig-Holstein
See details and how to joinNCT07444801
No phaseTaking people
Molecular Signatures in Inflammatory Skin Disease
Where
Kiel
People
300
Run by
Prof. Dr. Stephan Weidinger
See details and how to joinNCT03358693
No phaseTaking people
Disease Trajectories and Anti-cytokine Response Signatures in Atopic Dermatitis and Psoriasis
Where
Kiel
Age
0 years to 100 years
People
1,000
Run by
University Hospital Schleswig-Holstein
See details and how to joinNCT03361215
Phase 2Not yet taking people in Germany
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial to Evaluate the Efficacy and Safety of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated with Dupilumab.
Where
Berlin, Buxtehude, Hamburg
Age
18 years and over
People
50 worldwide
Run by
Aslan Pharmaceuticals Pte Ltd
See details and how to joinNCT05694884 · EU 2023-508329-28-00
No phaseTaking people
TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis
Where
Dresden, Hanover, Kiel
People
2,800
Run by
Technische Universität Dresden
See details and how to joinNCT03057860